Glucocorticoid-induced Tumour Necrosis Factor Receptor Related Protein (GITR) in Rheumatoid Arthritis
NCT03763201 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2020-07-07
Summary
This study aimed to measure serum and synovial fluid (SF) levels of GITR in patients with recent onset RA before and after initiation of therapy
Conditions
Interventions
- DIAGNOSTIC_TEST
-
measurement of GITR
serum and synovial fluid measurement of glucocorticoid-induced tumour necrosis factor receptor related protein
Sponsors & Collaborators
-
Benha University
lead OTHER
Principal Investigators
-
Waleed A Hassan, MD · Benha university- Qaluibya- Egypt
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-11-08
- Primary Completion
- 2020-09-15
- Completion
- 2020-09-15
Countries
- Egypt
Study Locations
More Related Trials
-
Biomarker Signature and Musculoskeletal Ultrasound Profile in Rheumatoid Arthritis Patients
NCT02476084 ·Status: COMPLETED
-
Effectiveness of Iguratimod Versus Placebo to Treat Early Rheumatoid Arthritis on MRI
NCT01893151 ·Status: UNKNOWN ·Phase: PHASE4
-
Study To Evaluate The Response To Enbrel And The Impact Of Rheumatoid Factor(RF) And Anti-Cyclic Citrullinated Peptide(Anti-CCP) In Rheumatoid Arthritis(RA) Patients
NCT04428424 ·Status: COMPLETED
-
Ultrasound Enthesitis Response in Psoriatic Arthritis
NCT03955861 ·Status: COMPLETED
-
Ultrasound and Withdrawal of Biological DMARDs in Rheumatoid Arthritis
NCT01602302 ·Status: TERMINATED ·Phase: PHASE4
-
Serum Biomarkers Analysis in Patients With AR Treated With Anti-TMF
NCT02804204 ·Status: UNKNOWN
-
This Study is to Investigate the Effect of Etanercept in Early Versus Delayed Referral for Management of Rheumatoid Arthritis Patients.
NCT04267614 ·Status: COMPLETED
-
Study To Evaluate The Impact Of Early Initiation Of Biological Treatment With Ankylosing Spondylitis
NCT04507763 ·Status: COMPLETED
-
Study Conducted in Subjects With Rheumatoid Arthritis Who Have Moderate to Severe Disease Activity Despite Methotrexate Therapy With or Without Other Non Biologic Disease Modifying Antirheumatic Drugs (DMARDs)for at Least 12 Weeks Prior to Screening
NCT01578850 ·Status: COMPLETED ·Phase: PHASE4
-
Study To Evaluate The Efficacy And Long-Term Adherence Of Spondyloarthropathies(SpA) Patients On Enbrel
NCT04507776 ·Status: COMPLETED
-
Improved Diagnostics and Monitoring of Polymyalgia Rheumatica
NCT04519580 ·Status: ACTIVE_NOT_RECRUITING
-
Study Evaluating the Clinical Remission in Early Aggressive Rheumatoid Arthritis
NCT00267852 ·Status: COMPLETED
-
An Observational Study to Describe in Routine Clinical Practice the Treatment Patterns of Usage of Biological DMARDs in RA Patients.
NCT02590562 ·Status: COMPLETED
-
Good EULAR Response In Patients With Early Rheumatoid Arthritis
NCT01558089 ·Status: COMPLETED
-
Single Dose Study Of GW856553 On A Protein That Is An Indicator For Rheumatoid Arthritis (RA)
NCT00256919 ·Status: COMPLETED ·Phase: PHASE2
-
Genetic and Immune Studies of Rheumatoid Arthritis and Related Conditions
NCT00001291 ·Status: COMPLETED
-
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
NCT01211678 ·Status: COMPLETED
-
The Effect of Corticotrophin (ACTH) in Combination With Methotrexate in Newly Diagnosed Rheumatoid Arthritis Patients
NCT01948388 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of the Persistence of Inflammation at Doppler Ultrasound Level on the Structural Evolution of Erosion in Rheumatoid Arthritis Treated With Biotherapy
NCT02531061 ·Status: COMPLETED ·Phase: NA
-
Prospective Study of Classification and Activity Assessment of Psoriatic Arthritis Based on Power Doppler (PD) Ultrasonography (PDUS)
NCT06730334 ·Status: RECRUITING
-
Assessment of Leflunomide Efficacy and Hepatotoxicity in Patients With Rheumatoid Arthritis Through Pharmacokinetic and Genetic Approaches
NCT04022525 ·Status: COMPLETED
-
Quantification of GADD34 Expression in RA
NCT02401165 ·Status: COMPLETED ·Phase: NA
-
Observational Registry of Patients With Rheumatoid Arthritis /Spondyloarthritis Using Biological or Targeted Synthetic DMARDs
NCT04139954 ·Status: UNKNOWN
-
Assessment of the Clinical and Medico-economic Impact of SinnoTest® in Patients With Rheumatoid Arthritis
NCT04117165 ·Status: WITHDRAWN ·Phase: NA
-
TNF and IL23 Blocking Agents Gene Expression Ratios in the Psoriatic Arthritis Synovium_(TIGERS) Study
NCT04261010 ·Status: COMPLETED ·Phase: NA